Home › Smoldering Multiple Myeloma › Colorado
Smoldering Multiple Myeloma clinical trials in Colorado
3 studies for Smoldering Multiple Myeloma are looking for participants at sites in Colorado.
Cities in Colorado
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
- Colorado Blood Cancer Institute, Denver
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06768489Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Rocky Mountain Cancer Centers-Aurora, Aurora
- Boulder Community Foothills Hospital, Boulder
- Rocky Mountain Cancer Centers-Boulder, Boulder
- and 11 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT03937635Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
- Colorado Blood Cancer Institute, Denver
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT05469893From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.